Loading
Immunocure
Immunocure develops an AI platform AxDrug to design and discover new drugs for cancer and other diseases integrated with in-house chemistry facility.
Funding
Every round, secondary, debt facility or acquisition involving Immunocure that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log in